Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

RO-3

Copy Product Info
🥰Excellent
Catalog No. T5513Cas No. 1026582-88-6

RO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor

RO-3

RO-3

Copy Product Info
🥰Excellent
Purity: 99.63%
Catalog No. T5513Cas No. 1026582-88-6
RO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$30In StockIn Stock
5 mg$64In StockIn Stock
10 mg$123In StockIn Stock
25 mg$289In StockIn Stock
50 mg$519In StockIn Stock
100 mg$743In StockIn Stock
1 mL x 10 mM (in DMSO)$126In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.63%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

RO-3 AI Summary
RO-3 exhibits antagonist activity at both the human recombinant P2X2/3 receptor expressed in human 1321N1 cells with an IC50 of 1995.26 nM and the rat recombinant P2X3 receptor expressed in CHO cells with an IC50 of 125.89 nM. Additionally, it has demonstrated antiviral activity against SARS-CoV-2 by inhibiting SARS-CoV-2 induced cytotoxicity in Caco-2 cells (0.13% inhibition at 10 µM after 48 hours) and Vero-6 cells (0.01% inhibition at 10 µM after 48 hours exposure to 0.01 MOI virus). The compound also shows inhibitory activity towards the SARS-CoV-2 3CL-Pro protease with a 3.058% inhibition at 20 µM concentration. Furthermore, RO-3 exhibits inhibitory activity towards the human HDAC6 enzyme, with 14.7% inhibition using a commercial peptide substrate and 2.23% inhibition with a custom peptide substrate..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
RO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor
Chemical Properties
Molecular Weight302.37
FormulaC16H22N4O2
Cas No.1026582-88-6
SmilesCOc1cc(Cc2cnc(N)nc2N)c(cc1OC)C(C)C
Relative Density.1.172 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 3.03 mg/mL (10.02 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (3.31 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.3072 mL16.5360 mL33.0721 mL165.3603 mL
5 mM0.6614 mL3.3072 mL6.6144 mL33.0721 mL
10 mM0.3307 mL1.6536 mL3.3072 mL16.5360 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy RO-3 | purchase RO-3 | RO-3 cost | order RO-3 | RO-3 chemical structure | RO-3 formula | RO-3 molecular weight